{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T19:12:08Z","timestamp":1774465928383,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.ygyno.2010.07.032","type":"journal-article","created":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T09:53:21Z","timestamp":1282902801000},"page":"259-264","source":"Crossref","is-referenced-by-count":89,"title":["Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience"],"prefix":"10.1016","volume":"119","author":[{"given":"Michele","family":"Peiretti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanna","family":"Zanagnolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni D.","family":"Aletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Bocciolone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Minig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Radice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2010.07.032_bb0005","series-title":"Cancer facts and figures\u00a02008","author":"American Cancer Society","year":"2009"},{"issue":"4","key":"10.1016\/j.ygyno.2010.07.032_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.ygyno.2010.07.032_bb0015","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/annonc\/mdi098","article-title":"Cancer incidence and mortality in Europe, 2004","volume":"16","author":"Boyle","year":"2005","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2010.07.032_bb0020","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0039-6109(05)70171-7","article-title":"Cytoreductive surgery for ovarian cancer","volume":"81","author":"Randall","year":"2001","journal-title":"Surg Clin North Am"},{"issue":"3 Pt 2","key":"10.1016\/j.ygyno.2010.07.032_bb0025","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1006\/gyno.1994.1346","article-title":"Epithelial ovarian carcinoma: principles of primary surgery","volume":"55","author":"Hoskins","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2010.07.032_bb0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1200\/JCO.1989.7.4.457","article-title":"Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study","volume":"7","author":"Omura","year":"1989","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ygyno.2010.07.032_bb0035","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0040","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/gyno.1995.1027","article-title":"The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer","volume":"56","author":"Makar","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1006\/gyno.1997.4839","article-title":"Does debulking surgery improve survival in biologically aggressive ovarian carcinoma?","volume":"67","author":"Le","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/gyno.2001.6344","article-title":"Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator","volume":"83","author":"Bristow","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0060","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0065","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1002\/1097-0142(19931215)72:12<3663::AID-CNCR2820721218>3.0.CO;2-S","article-title":"National survey of ovarian carcinoma. Part V: the impact of physician's specialty on patients' survival","volume":"72","author":"Nguyen","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0080","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0085","series-title":"Tumors of the female pelvic organs","author":"Meigs","year":"1934"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0090","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0095","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC\u2013IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0100","first-page":"56","article-title":"The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and IV","volume":"8","author":"Kuhn","year":"1998","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2010.07.032_bb0105","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ygyno.2010.07.032_bb0110","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.ejso.2010.06.006","article-title":"Patterns of care in surgery for ovarian cancer in Europe","volume":"36","author":"Verleye","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0115","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1200\/JCO.2005.02.1287","article-title":"Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 trial","volume":"23","author":"Crawford","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0120","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1200\/JCO.2007.11.8992","article-title":"Concept of optimal surgical cytoreduction in advanced ovarian cancer: a brief critique and a call for action","volume":"25","author":"Markman","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2010.07.032_bb0125","series-title":"Paper presented at: the International Gynecologic Cancer Society meeting","article-title":"Randomized trial comparing primary debulking surgery with neoadjuvant chemotherapy followed by interval debulking in stage IIIC\u2013IV ovarian, fallopian tube and peritoneal cancer","author":"Vergote","year":"2008"},{"issue":"1","key":"10.1016\/j.ygyno.2010.07.032_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2005.07.123","article-title":"Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon","volume":"100","author":"Aletti","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810005615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825810005615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T04:01:14Z","timestamp":1740456074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825810005615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0090825810005615"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2010.07.032","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}